1062214-10-1Relevant articles and documents
Development of triarylsulfonamides as novel anti-inflammatory agents
Greig, Iain R.,Coste, Emmanuel,Ralston, Stuart H.,Van 'T Hof, Robert J.
, p. 816 - 820 (2013/03/14)
Triaylsulfonamides were identified as novel anti-inflammatory agents, acting by inhibition of RANKL and TNFα signaling. Structure-activity studies led to the identification of compounds with in vitro potencies of 50 >50 μM). A representative compound (4k, ABD455) was able to completely prevent inflammation in vivo in a prevention model and was highly effective at controlling inflammation in a treatment model.